EASTERN COOPERATIVE ONCOLOGY GROUP

东方肿瘤合作组

• 批准号: 6172402
• 负责人: DAVID H JOHNSON
• 金额: $ 41.31万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1989
• 资助国家: 美国
• 起止时间: 1989-05-01 至 2004-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6172402
• 关键词: AIDS; antineoplastics; biological response modifiers; bone marrow transplantation; brain neoplasms; breast neoplasms; cancer prevention; clinical research; clinical trials; combination cancer therapy; combination chemotherapy; cooperative study; fluorescent in situ hybridization; gastrointestinal neoplasms; gene therapy; head /neck neoplasm; health behavior; human subject; human therapy evaluation; leukemia; lymphoma; melanoma; minimal residual disease; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer pharmacology; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; neoplasm /cancer vaccine; nucleic acid sequence; pathology; prognosis; reproductive system neoplasm; thorax neoplasm; tissue resource /registry; urinary tract neoplasms

The principle objectives of this grant are to secure funding to support the clinical research activity of the Eastern Cooperative Oncology Group (ECOG) at Vanderbilt University Medical School, to facilital patient accrual to ECOG trials, and to expand the scientific and administrative contributions made to ECOG sponsored clinical trials and laboratory studies, 2) to further increase the scientific and administrative contributions to ECOG by Vanderbilt investigators, 3) to continue the development of innovative treatment programs for common solid tumors and hematologic malignancies, and 4) to maintain a high level of data quality and management for which the institution is known. These goals will be achieved through the close interaction of investigators from medical oncology, radiation oncology, pathology and the section of surgical sciences. The interactions between Vanderbilt investigations and other ECOG institutions will be facilitated by the presence of Vanderbilt investigators on numerous ECOG disease oriented committees and modality committees. The Vanderbilt Cancer Center has in place all the necessary elements for the successful execution of cooperative group clinical trials including an outstanding data management staff, excellent outpatient and inpatient facilities in which this work will be undertaken and a long history of cooperative group participation.

该补助金的主要目标是确保资金支持范德比尔特大学医学院东部肿瘤协作组（ECOG）的临床研究活动，促进ECOG试验的患者招募，并扩大对ECOG申办的临床试验和实验室研究的科学和行政贡献，2）进一步增加范德比尔特研究者对ECOG的科学和管理贡献，3）继续开发常见实体瘤和血液恶性肿瘤的创新治疗方案，及4）维持高水平的数据质素及管理，而这是该机构的强项。这些目标将通过来自内科肿瘤学、放射肿瘤学、病理学和外科科学部门的研究人员的密切互动来实现。 范德比尔特研究者在众多ECOG疾病导向委员会和模式委员会中的存在将促进范德比尔特研究与其他ECOG机构之间的互动。 范德比尔特癌症中心具备成功执行合作组临床试验的所有必要要素，包括优秀的数据管理人员、开展此项工作的优秀门诊和住院设施以及合作组参与的悠久历史。